Allopurinol may cut diabetes patients' risk of cardiac death

09/5/2013 | (U.K.) · Scotsman (Edinburgh), The

Type 2 diabetes patients who received the gout medication allopurinol showed reduced thickness of the heart muscle wall compared with those who took a placebo, according to a small study in the Journal of the American College of Cardiology. The findings suggest that while skin reactions are a common side effect, the drug may help reduce cardiac deaths in diabetes patients.

View Full Article in: (U.K.) · Scotsman (Edinburgh), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN